Investing.com – Stocks of the Week

While the main story this week was the Federal Reserve’s more cautious path for rate cuts next year, individual stocks and sector stories brought volatility to big names. Here are Investing.com’s stocks of the week: Micron Technology (NASDAQ:MU), Novo Nordisk (NYSE:NVO), MicroStrategy, and Coinbase (NASDAQ:COIN).

Micron Technology

Micron Technology shares tumbled more than 16% on Thursday after reporting its latest quarterly earnings, which disappointed investors.

Although its Q1 EPS of $1.79 exceeded the analyst estimate of $1.73 and revenue for the quarter reached $8.71 billion, above the consensus estimate of $8.68 billion, Micron forecast quarterly revenue and profit below Wall Street estimates after the earnings release.

For Q2 2025, Micron projects an EPS between $1.33 and $1.53, lower than the consensus of $1.97, and revenue between $7.7 billion and $8.1 billion, below the consensus estimate of $8.97 billion.

Following the earnings, JPMorgan lowered its target for the stock to $145 from $180, stating, “despite the near-term weakness, we continue to believe the down-cycle in memory will be short-lived.” They expect market conditions to improve in the latter part of 2025 as “leading-edge DRAM supply remains tight and strong AI server demand continues to drive growth in HBM/DDR5.”

Novo Nordisk

Friday was challenging for Novo Nordisk shares, with the stock down 17.4% at the time of writing.

This decline was triggered by disappointing results from its phase 3 trial of CagriSema, its next-generation obesity drug. The company’s REDEFINE 1 trial showed that individuals treated with CagriSema (a combination of cagrilintide and semaglutide) achieved a weight loss of 22.7% after 68 weeks. However, this fell short of the target of 25%.

In response to the news, rival Eli Lilly's shares rose, and Wolfe Research analysts commented, “While we didn't expect CagriSema to be a formidable competitor to Lilly's Zepbound, we now see Lilly in a true class of its own with Zepbound, orforglipron, and retatrutide.”

MicroStrategy and Coinbase

The price of Bitcoin initially soared to over $108,000 earlier in the week but fell to a low of $92,118 on Friday.

Although MicroStrategy (MSTR) and Coinbase (COIN) experienced some gains on Friday, increasing by 8.1% and 1%, respectively, both stocks had seen declines for most of the week. MicroStrategy is down around 14% over the last five days, while Coinbase has declined over 11%.

Despite an initial plunge on Friday, Bitcoin has regained some ground, trading at $97,075 as of 13:58 ET.